Flecainide - PDFSEARCH.IO - Document Search Engine

Flecainide
Results: 51

#	Item
21	Concerns: ______________________ Date of birth: Add to Reading List Source URL: www.brugadadrugs.org Language: English - Date: 2014-04-21 10:43:16 Sodium channel blockers Medicine Amines Alcohols Brugada syndrome Syndromes Lidocaine Flecainide Analgesic Chemistry Antiarrhythmic agents Organic chemistry
22	Microsoft Word - Hotline Newsletter[removed]doc Add to Reading List Source URL: www.iowapoison.org Language: English - Date: 2014-10-02 07:53:43 Sodium channel blockers Cardiac electrophysiology Sodium bicarbonate Antiarrhythmic agent Tricyclic antidepressant Flecainide Sodium channel Dextropropoxyphene Sodium Chemistry Electrophysiology Benzamides
23	Patients With an Asymptomatic Brugada Electrocardiogram Should Undergo Pharmacological and Electrophysiological Testing Pedro Brugada, Ramon Brugada and Josep Brugada Circulation. 2005;112:[removed]doi: [removed]CIRCULATIO Add to Reading List Source URL: emsofficehours.com Language: English - Date: 2014-07-22 20:09:30 Circulatory system Brugada syndrome Ventricular fibrillation Long QT syndrome Sudden cardiac death Ventricular tachycardia Arrhythmogenic right ventricular dysplasia Nav1.5 Flecainide Cardiac dysrhythmia Health Medicine
24	How to Perform and Interpret Provocative Testing for the Diagnosis of Brugada Syndrome, Long-QT Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia Manoj N. Obeyesekere, George J. Klein, Simon Modi, Peter Add to Reading List Source URL: emsofficehours.com Language: English - Date: 2014-07-22 20:10:12 Circulatory system Brugada syndrome Catecholaminergic polymorphic ventricular tachycardia Long QT syndrome Flecainide Ventricular tachycardia QT interval Sudden cardiac death Tachycardia Cardiac dysrhythmia Medicine Health
25	Oral Propafenone Drug Shortage Important notes: Ideally, the patient should see cardiologist for determination of the most appropriate alternative agent and how the agents should be switched. Failing that, a cardiology c Add to Reading List Source URL: medsask.usask.ca Language: English - Date: 2013-11-26 12:36:22 Cardiology Antiarrhythmic agents Flecainide Propafenone Supraventricular tachycardia Amiodarone Atrial fibrillation AV nodal reentrant tachycardia Sotalol Chemistry Organic chemistry Cardiac dysrhythmia
26	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MULTAQ safely and effectively. See full prescribing information for MULTAQ. MULTAQ (dronedarone) Tablets Initial U.S Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-03-11 17:03:36 Benzofurans Dronedarone Sulfonamides Amines Organofluorides Amiodarone Norfloxacin Digoxin Flecainide Chemistry Organic chemistry Antiarrhythmic agents
27	BETAPACE® (sotalol HCl) To minimize the risk of induced arrhythmia, patients initiated or reinitiated on Betapace® should be placed for a minimum of three days (on their maintenance dose) in a facility that can provide Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-08-24 14:44:33 Cardiology Antiarrhythmic agents Potassium channel blockers Cardiac electrophysiology Amines Torsades de pointes Ventricular tachycardia Long QT syndrome Flecainide Chemistry Cardiac dysrhythmia Medicine
28	Page[removed]safety for the most part is safety of the 2 Add to Reading List Source URL: www.fda.gov Language: English - Date: 2007-11-13 11:43:14 Antiarrhythmic agents Circulatory system Cardiac electrophysiology Potassium channel blockers Benzofurans Atrial fibrillation Amiodarone Flecainide Cardiac dysrhythmia Chemistry Organic chemistry
29	Interdisciplinary Review Team for QT Studies Consultation: Multiple Ascending Dose (MAD) Study Review IND Add to Reading List Source URL: www.fda.gov Language: English Eli Lilly and Company Organofluorides Piperidines Phenols Dextropropoxyphene Sertindole Flecainide QT interval Torsades de pointes Chemistry Organic chemistry Amines
30	• Consider reducing the dose in patients with hepatic impairment, significant widening of the QRS complex, or second or third degree AV block. (2) --------------------- DOSAGE FORMS AND STRENGTHS[removed]Tablets: 1 Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-03-26 14:19:35 Medicine Antiarrhythmic agents Sodium channel blockers Amines Medical emergencies Propafenone Flecainide Amiodarone Proarrhythmia Cardiac dysrhythmia Chemistry Organic chemistry

UPDATE